Your Messages Inbox
Your Article Summary
See Latest ArticlesDuloxetine treatment for women with premenstrual dysphoric disorder: a single-blind trial
International Journal of Neuropsychopharmacology, 08/17/09
Ramos MG et al. – Significant improvements were demonstrated by secondary measures, including reduction in self–rated functional impairment and improvement in quality of life. The main side–effects associated with duloxetine were dry mouth, nausea, drowsiness, insomnia, decreased appetite, decreased libido, and sweating. Duloxetine was effective and generally well tolerated in the treatment of PMDD.
Related Articles
The association between arthritis and psychiatric disorders; results from a longitudinal population-based study
Journal of Psychosomatic Research, 10/12/09
Relevance Score: 47%
Clinical management of motility disorders in children
Seminars in Pediatric Surgery, 10/01/09
Relevance Score: 47%
Comorbidity in Adults With Attention-Deficit Hyperactivity Disorder
Canadian Journal of Psychiatry, 10/20/09
Relevance Score: 46%
Do mental disorders and eating patterns affect long-term weight loss maintenance
General Hospital Psychiatry, 10/19/09
Relevance Score: 46%
Obsessive-compulsive spectrum and disorders of the skin
Expert Review of Dermatology, 10/14/09
Relevance Score: 46%
Today in Drug Trials...keeping you current
Receive free subspecialty "5-minute updates" via email
ARIAD Announces Full Enrollment in Phase 3 Succeed Trial Evaluating Ridaforolimus in Patients with Metastatic Sarcomas
ARIAD Pharmaceuticals, 12/18/09
Phase I trial of motexafin gadolinium and doxorubicin in the treatment of advanced malignancies
Investigational New Drugs, 12/18/09
Prognostic Factors in Idiopathic Pulmonary Fibrosis
The American Journal of the Medical Sciences, 12/17/09
Article Search
Sponsor